New AHA/ASA scientific advisory on stroke prevention in atrial fibrillation

The American Heart Association / American Stroke Association has published a scientific advisory which includes new oral anticoagulants to prevent stroke in patients with atrial fibrillation. For many years, the only oral anticoagulant available has been warfarin (Coumadin). Alternatives have now been introduced. Dabigatran (Pradaxa) was approved by FDA in October 2010, followed by rivaroxaban … Read more…